A spokesperson for Goldman Sachs told Business Insider that while the bank does drug test new hires, the screening process does not include marijuana.
The spokesperson declined to comment further regarding the specifics of the bank's drug testing policy.
Goldman, for its part, was instrumental in one of the biggest deals in the cannabis industry to date. The bank advised Constellation Brands, an existing client, on the Corona maker's $4 billion purchase of an equity stake in Canadian marijuana cultivator Canopy growth.